siRNA therapy decreases triglycerides in clients with uncommon health condition

.INVESTIGATION HIGHLIGHT.19 September 2024.

Plozasiran reduced triglyceride levels through 80% and also reduced the threat of pancreatitis in clients along with persistent chylomicronemia, with or even without a hereditary medical diagnosis.